Skip to main content
. 2021 Mar 7;10(3):310. doi: 10.3390/pathogens10030310

Figure 2.

Figure 2

Vascularisation factor expression profile in the study population. 1: Persons with OAE 2: African controls 3: Europeans with a neurological condition but no epilepsy 4: Europeans with epilepsy. Only difference between 2 groups with a p-value < 0.05 are shown. (A). VCAM expression in ng/mL; (B). VEGF-C expressions in ng/mL.